BORDEAUX, France

Patrick Blanco

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Patrick Blanco - Innovator in Pharmaceutical Compositions

Introduction

Patrick Blanco is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the area of reducing CD95-mediated cell motility. His work has implications for cancer treatment and autoimmune diseases.

Latest Patents

Patrick Blanco holds a patent for "Compounds and pharmaceutical compositions for reducing CD95-mediated cell motility." This invention focuses on the reduction of CD95-mediated cancer cell motility and lymphocyte motility. The patent describes a novel family of compounds that disrupt the CD95/PLCγ1 interaction, neutralizing the CD95-mediated calcium signaling pathway. This innovation has potential applications in treating B-cell tumors and autoimmune inflammatory diseases.

Career Highlights

Throughout his career, Patrick Blanco has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université de Rennes 1. His research has contributed to advancements in understanding cell motility and its implications for various diseases.

Collaborations

Patrick Blanco has collaborated with notable colleagues, including Pierre Vacher and Patrick Legembre. These partnerships have enhanced his research and contributed to the development of his patented innovations.

Conclusion

Patrick Blanco's work in pharmaceutical compositions represents a significant advancement in the treatment of cancer and autoimmune diseases. His innovative approach to reducing CD95-mediated cell motility has the potential to impact many lives positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…